Analystreport

Acasti Pharma Inc (NASDAQ: ACST) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating.

Acasti Pharma, Inc. - Class A  (ACST) 
Last acasti pharma, inc. - class a earnings: 2/14 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: acastipharma.com/investors